Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             121 results found
no title author magazine year volume issue page(s) type
1 Actions of anti-inflammatory drugs Lands, William E.M.
1981
2 C p. 78-80
3 p.
article
2 Active peptides in amphibian skin Nakajima, Terumi
1981
2 C p. 202-205
4 p.
article
3 Adrenaline-mediated hypertension: a clue to the antihypertensive effect of β-adrenoceptor blocking drugs? Majewski, H.
1981
2 C p. 24-26
3 p.
article
4 β-Adrenergic receptor subtypes Leclerc, G.
1981
2 C p. 18-20
3 p.
article
5 Age-related decrease in beta adrenoceptor activity of the cardiovascular system Fleisch, Jerome H.
1981
2 C p. 337-339
3 p.
article
6 A hypothetic functional model of the cardiac cell membrane Kelemen, K.
1981
2 C p. 101-104
4 p.
article
7 Alpha-adrenergic receptors and the regulation of lipolysis in adipose tissue Lafontan, Max
1981
2 C p. 126-129
4 p.
article
8 Aminergic neurones, phenolamine pathways and octopamine Dougan, Donald F.H.
1981
2 C p. 113-116
4 p.
article
9 Analysis of dose-response curves Waud, D.R.
1981
2 C p. 52-55
4 p.
article
10 Anticonvulsant therapy: present and future Eadie, M.J.
1981
2 C p. 37-39
3 p.
article
11 Antidepressant drugs: will new findings change the present theories of their action? Maj, J.
1981
2 C p. 80-83
4 p.
article
12 Antiestrogens Mukku, Venkat R.
1981
2 C p. 98-101
4 p.
article
13 A study of intravascular platelet aggregation by continuous platelet counting Smith, G.M.
1981
2 C p. 105-107
3 p.
article
14 Author index 1981
2 C p. 343-345
3 p.
article
15 Benzene induced bone-marrow insufficiency Haak, H.L.
1981
2 C p. 265-267
3 p.
article
16 Benzodiazepine receptors: are there endogenous ligands in the brain? Möhler, H.
1981
2 C p. 116-119
4 p.
article
17 Biopterin cofactor and regulation of monoamine-synthesizing mono-oxygenases Nagatsu, Toshiharu
1981
2 C p. 276-279
4 p.
article
18 Brain mechanisms underlying aggressive behaviour: a re-evaluation Karli, Pierre
1981
2 C p. 285-286
2 p.
article
19 Brain noradrenaline, depression and antidepressant drugs: facts and hypothesis Kostowski, Wojciech
1981
2 C p. 314-317
4 p.
article
20 Brain peptides and blood pressure control Unger, Thomas
1981
2 C p. 289-292
4 p.
article
21 Can the future of pharmacology be anticipated? Habermann, E.
1981
2 C p. 56-59
4 p.
article
22 Cardiac histamine: a mediator in search of a function Trzeciakowski, Jerome P.
1981
2 C p. 14-17
4 p.
article
23 Cardioactive drugs and the calcium slow channel in the heart Gargouïl, Y.M.
1981
2 C p. 44-47
4 p.
article
24 Cardiotonic agents and the sodium transient Akera, Tai
1981
2 C p. 191-193
3 p.
article
25 Catecholamine-induced modification of the functional state of β-adrenergic receptors Perkins, John P.
1981
2 C p. 326-328
3 p.
article
26 Central nervous system effects of angiotensin II Buckley, Joseph P.
1981
2 C p. 161-162
2 p.
article
27 Clinical significance of plasma binding of basic drugs De Leve, L.D.
1981
2 C p. 283-284
2 p.
article
28 Clonidine, a drug with many faces? Kobinger, W.
1981
2 C p. 194-196
3 p.
article
29 Clonidine withdrawal hypertension in spontaneously hypertensive rats Saito, Hideya
1981
2 C p. 176-177
2 p.
article
30 Conformotional analysis in medicinal chemistry Tollenaere, J.P.
1981
2 C p. 273-275
3 p.
article
31 Control of contraction of vascular muscle: relation to hypertension Daniel, E.E.
1981
2 C p. 220-223
4 p.
article
32 Control of the contractile process in muscle Schaub, M.C.
1981
2 C p. 279-282
4 p.
article
33 Denervation supersensitivity in salivary glands Stefano, Francisco J.E.
1981
2 C p. 107-109
3 p.
article
34 Direct binding studies of adenosine receptors Schwabe, Ulrich
1981
2 C p. 299-303
5 p.
article
35 Discovery of antitumor agents from natural sources Suffness, Matthew
1981
2 C p. 307-310
4 p.
article
36 Does phosphatidylinositol breakdown control the Ca2+-gating mechanism? Cockcroft, S.
1981
2 C p. 340-342
3 p.
article
37 Dopamine receptors and cyclic AMP: a decade of progress Kebabian, John W.
1981
2 C p. 69-71
3 p.
article
38 Drug evaluation in developing countries Salako, L.A.
1981
2 C p. 84-85
2 p.
article
39 Drugs and the acute porphyrias Moore, M.R.
1981
2 C p. 330-334
5 p.
article
40 Drug selection: controversies and opportunities Tognoni, Gianni
1981
2 C p. 138-141
4 p.
article
41 Drug use in athletics Burks, Thomas F.
1981
2 C p. 66-68
3 p.
article
42 Editorial Board 1981
2 C p. iii-
1 p.
article
43 Enkephalin (opiate) receptors in the intestine Oka, Tetsuo
1981
2 C p. 328-330
3 p.
article
44 Epoxide hydrolase and hepatocarcinogenesis Griffin, Martin J.
1981
2 C p. 257-258
2 p.
article
45 Functional heterogeneity among liver cells: implications for drug toxicity and metabolism Sweeney, G.D.
1981
2 C p. 141-144
4 p.
article
46 GABA receptors Enna, S.J.
1981
2 C p. 62-64
3 p.
article
47 Glucocorticoids, phospholipase A2 and inflammation Flower, Rod
1981
2 C p. 186-189
4 p.
article
48 Histamine receptors in brain as targets for tricyclic antidepressants Schwartz, Jean-Charles
1981
2 C p. 122-125
4 p.
article
49 How do drugs initiate contraction in smooth muscles? Brading, Alison F.
1981
2 C p. 261-265
5 p.
article
50 How fast do drugs work? Colquhoun, D.
1981
2 C p. 212-217
6 p.
article
51 Hyperosmotic infusions and the treatment of hypovolemic shock Rocha-e-Silva Jr, M.
1981
2 C p. 252-255
4 p.
article
52 Hypothalamic releasing hormones Buckingham, Julia C.
1981
2 C p. 335-337
3 p.
article
53 Identification and significance of beta-adrenoceptor subtypes Nahorski, Stefan R.
1981
2 C p. 95-98
4 p.
article
54 Immunoregulation by sympathetic nervous system Besedovsky, H.O.
1981
2 C p. 236-238
3 p.
article
55 Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics Ferreira, S.H.
1981
2 C p. 183-186
4 p.
article
56 Inotropic effects of activation and pharmacological mechanisms in cardiac muscle Joachim Mensing, H.
1981
2 C p. 303-307
5 p.
article
57 Interrelationships between clonidine and histaminergic mechanisms Karpannen, Heikki
1981
2 C p. 35-37
3 p.
article
58 Is it possible to reveal the spectrum of emotiopsychotropic effects of tranquilizers in experiments on animals? Valdman, A.V.
1981
2 C p. 72-75
4 p.
article
59 Isolated nephron segments as pharmacological tools Stoner, Larry C.
1981
2 C p. 3-5
3 p.
article
60 Learning and memory facilitators: experimental definition and current status Heise, George A.
1981
2 C p. 158-160
3 p.
article
61 Levamisole and sodium diethyldithiocarbamate Renoux, G.
1981
2 C p. 248-249
2 p.
article
62 Liposomes as a drug delivery system Juliano, Rudolph L.
1981
2 C p. 39-42
4 p.
article
63 Main trends in the search for new neuromuscular blocking agents Kharkevich, D.A.
1981
2 C p. 218-220
3 p.
article
64 Mechanisms of toxicity Aldridge, W.N.
1981
2 C p. 228-231
4 p.
article
65 Medicines and structural information Brekhman, I.I.
1981
2 C p. 1-3
3 p.
article
66 Membrane receptors and hormone action I new trends related to receptor structure and receptor regulation Hollenberg, Morley D.
1981
2 C p. 320-323
4 p.
article
67 Metabolic activation and inactivation of chemical mutagens and carcinogens Guenthner, Thomas M.
1981
2 C p. 129-132
4 p.
article
68 Methylthilation: a new pathway of drug metabolism Stillwell, W.G.
1981
2 C p. 250-252
3 p.
article
69 Mixed complex formation: new therapeutic approaches. Part I Schubert, Jack
1981
2 C p. 6-9
4 p.
article
70 Mixed complex formation: new therapeutic approaches. Part II Schubert, Jack
1981
2 C p. 50-52
3 p.
article
71 Model systems for the study of sexual differentiation of the nervous system Arnold, Arthur P.
1981
2 C p. 148-149
2 p.
article
72 Monitoring plasma concentrations of psychotherapeutic drugs Hollister, Leo.E.
1981
2 C p. 89-92
4 p.
article
73 On the discovery of isoprenaline Konzett, H.
1981
2 C p. 47-49
3 p.
article
74 On the rational choice of cardiac glycoside Rietbrock, Norbert
1981
2 C p. 206-209
4 p.
article
75 Opiate receptors: some recent developments Simon, E.J.
1981
2 C p. 155-158
4 p.
article
76 Peripheral actions of apamin Jenkinson, D.H.
1981
2 C p. 318-320
3 p.
article
77 Peripheral opiate receptor mechanisms Hughes, John
1981
2 C p. 21-24
4 p.
article
78 Pharmacological aspects of coronary arterial spasm Sakanashi, Matao
1981
2 C p. 234-236
3 p.
article
79 Pharmacology of some natural products of China Xu, Bin
1981
2 C p. 271-272
2 p.
article
80 Polymorphism of drug oxidation in man: novel findings Eichelbaum, Michel
1981
2 C p. 31-34
4 p.
article
81 Postjunctional supersensitivity: a cellular homeostatic mechanism Fleming, William W.
1981
2 C p. 152-154
3 p.
article
82 Post-marketing surveillance: how many patients? Lewis, J.A.
1981
2 C p. 93-94
2 p.
article
83 Psychic dependence on opioids: mediated by dopaminergic mechanisms in the striatum? Kuschinsky, Klaus
1981
2 C p. 287-289
3 p.
article
84 Rapid tissue fixation by microwave irradiation Maruyama, Yuji
1981
2 C p. 239-241
3 p.
article
85 Recent developments in histamine H2-antagonists Brittain, R.T.
1981
2 C p. 310-313
4 p.
article
86 Screening methods of drug dependence liability using small animals Yamamoto, Ken-ichi
1981
2 C p. 267-270
4 p.
article
87 Sedative-hypnotic tolerance and physical dependence Okamoto, Michiko
1981
2 C p. 9-13
5 p.
article
88 Smoking and the behavioral effects of nicotine Bättig, K.
1981
2 C p. 145-147
3 p.
article
89 Some aspects of data management in multi-center clinical trials Chan, Y.K.
1981
2 C p. 29-31
3 p.
article
90 Spinal reflexes: what can they tell the pharmacologist? Jurna, Ilmar
1981
2 C p. 241-243
3 p.
article
91 Status of the cytochrome P-450 cycle Schenkman, John B.
1981
2 C p. 150-152
3 p.
article
92 Subject index 1981
2 C p. 346-347
2 p.
article
93 Substance P in sensory neurons Leeman, Susan E.
1981
2 C p. 119-121
3 p.
article
94 Tetramine disulfides: a new tool in α-adrenergic pharmacology Melchiorre, Carlo
1981
2 C p. 209-211
3 p.
article
95 The Australian National blood pressure study Doyle, A.E.
1981
2 C p. 293-296
4 p.
article
96 The autonomic pharmacology of the urinary bladder and urethra: a neglected area Downie, John W.
1981
2 C p. 163-165
3 p.
article
97 The challenge of industrial research: a pharmacologist's view on his move from academe to industry Straughan, D.W.
1981
2 C p. 27-28
2 p.
article
98 The classification of beta-adrenoceptors, 1 Daly, M.J.
1981
2 C p. 168-169
2 p.
article
99 The classification of beta-adrenoceptors, 2 Ariëns, E.J.
1981
2 C p. 170-173
4 p.
article
100 The collaborative development of a new family of antineoplastic drugs Cheng, C.C.
1981
2 C p. 223-224
2 p.
article
101 The confusion about additive combinations Pöch, G.
1981
2 C p. 256-257
2 p.
article
102 The controversial problem of insulin action Walaas, Otto
1981
2 C p. 196-198
3 p.
article
103 The effects of chemicals on hepatic heme biosynthesis Marks, Gerald S.
1981
2 C p. 59-61
3 p.
article
104 The interaction of drugs with mitochondrial functions: a possible mechanism for certain pharmacological effects Noack, E.
1981
2 C p. 225-227
3 p.
article
105 The move from academe to industry: a personal view Day, M.D.
1981
2 C p. 110-113
4 p.
article
106 Theoretical pharmacology: the quantitative identification of receptors Tallarida, Ronald J.
1981
2 C p. 231-234
4 p.
article
107 The oxicams: a new class of nonsteroidal anti-inflammatory agents Lombardino, Joseph G.
1981
2 C p. 132-135
4 p.
article
108 The pathophysiology of trace metal: neurotransmitter interaction in the CNS Donaldson, John
1981
2 C p. 75-78
4 p.
article
109 The puzzling ‘cascade’ of multiple receptors for dopamine Cools, A.R.
1981
2 C p. 178-183
6 p.
article
110 The relationship of diarrhea and drug therapy Feldman, Stuart
1981
2 C p. 165-167
3 p.
article
111 The requirement for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators Furchgott, Robert F.
1981
2 C p. 173-176
4 p.
article
112 The role of plasma level monitoring in cancer chemotherapy Donehower, Ross C.
1981
2 C p. 64-66
3 p.
article
113 The spinal site of action of morphine in pain relief: from basic research to clinical applications Le Bars, D.
1981
2 C p. 323-325
3 p.
article
114 The treatment of obesity: diet or drug? Jones, Dennis
1981
2 C p. 199-202
4 p.
article
115 The use of L-DOPA in Parkinson's disease: a 20 year follow-up Barbeau, André
1981
2 C p. 297-299
3 p.
article
116 Transmitter candidates in the retina Watling, Keith J.
1981
2 C p. 244-247
4 p.
article
117 Ubiquitous effects of the vitamin D endocrine system Walters, Marian R.
1981
2 C p. 42-44
3 p.
article
118 What imipramine has contributed to pharmacokinetics Bickel, M.H.
1981
2 C p. 259-261
3 p.
article
119 What is the clinical meaning of the acetylator phenotype? du Souich, Patrick
1981
2 C p. 189-191
3 p.
article
120 Why is phosphatidylinositol degraded in response to stimulation of certain receptors? Michell, Robert H.
1981
2 C p. 86-89
4 p.
article
121 Xenobiotic and endobiotic metabolizing enzymes: an overstretched discrimination? Jenner, Peter
1981
2 C p. 135-137
3 p.
article
                             121 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands